DNA Damage/DNA Repair

The DNA in a human cell receives tens of thousands of damages per day due to both external (exogenous) and internal (endogenous) stress. The exogenous damages are caused by chemical contamination, UV light, ionizing radiation and alkylation/methylation etc, while the endogenous damages are coming from oxidation, alkylation and hydrolysis of bases etc. Since single strand and double strand breaks of DNA will occur after the damage, unrepaired DNA damage leads to cell senescent, apoptosis and malignancies etc. To overcome this threat, cell has developed DNA damage response, to detect DNA damage and mediate its repair.
DNA repair involves multiple mechanisms such as mismatch, base excision, and nucleotide excision repair etc. A group of proteins and pathways are participated in those processes. ATM/ATR kinases and DNA-PK are crucial for the detection of the DNA damage. Chromatin remodelers regulate chromatin accessibility for the DNA repair factors to function. RPA, Rad51 and the fanconi anemia proteins act directly on repairing the DNA damage. p53 network, the RAS GTPase superfamily, and the ubiquitin system also play important part in the DNA damage response. Aberrant DNA damage response is linked to aging, cancer and immune diseases.
-   A4452 Mitomycin C3 CitationSummary: Inhibits DNA synthesis,antibiotic and antitumor agent A4452 Mitomycin C3 CitationSummary: Inhibits DNA synthesis,antibiotic and antitumor agent
-   A4098 PCI-24781 (CRA-024781)Target: Histone Deacetylases (HDACs)Summary: Pan-HDAC inhibitor A4098 PCI-24781 (CRA-024781)Target: Histone Deacetylases (HDACs)Summary: Pan-HDAC inhibitor
-   A3925 Voreloxin HydrochlorideSummary: Antineoplastic naphthyridine analogue A3925 Voreloxin HydrochlorideSummary: Antineoplastic naphthyridine analogue
-   A4524 4-HQNSummary: PARP inhibitor A4524 4-HQNSummary: PARP inhibitor
-   A4071 Fluorouracil (Adrucil)12 CitationTarget: Thymidylate SynthaseSummary: Antitumor agent;inhibitor of thymidylate synthase A4071 Fluorouracil (Adrucil)12 CitationTarget: Thymidylate SynthaseSummary: Antitumor agent;inhibitor of thymidylate synthase
-   A4097 CUDC-907Target: Histone Deacetylases (HDACs)|PI3KSummary: Potent PI3K/HDAC inhibitor A4097 CUDC-907Target: Histone Deacetylases (HDACs)|PI3KSummary: Potent PI3K/HDAC inhibitor
-   A3924 VoreloxinSummary: Topo II inhibitor A3924 VoreloxinSummary: Topo II inhibitor
-   A4164 AZD2461Target: PARPSummary: Novel PARP inhibitor A4164 AZD2461Target: PARPSummary: Novel PARP inhibitor
-   A4096 Belinostat (PXD101)2 CitationTarget: Histone Deacetylases (HDACs)Summary: Hydroxamate-type HDAC inhibitor A4096 Belinostat (PXD101)2 CitationTarget: Histone Deacetylases (HDACs)Summary: Hydroxamate-type HDAC inhibitor
-   A3872 TH-302Summary: Hypoxia-activated prodrug,inhibits H460/HT29 cell growth A3872 TH-302Summary: Hypoxia-activated prodrug,inhibits H460/HT29 cell growth
